C71T
CANCELLED SECTION 71
17/07/2026
Voltar para busca
Dado oficial do USPTO
IMMODULON
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
28
Atualização mais recente
11/08/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42, 44
Data de depósito
24/09/2018
Data de registro
31/12/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/07/2026
Última transação
11/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
GB
Examinador
DICKSON, RACHAEL
Unidade examinadora
N70
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized wording "IMMODULON", where "IMM" is in white and surrounded by a shaded teal circle and "ODULON" is in dark blue. All other instances of the color white in the mark represent background and/or transparent areas only and are not claimed as features of the mark.
Titulares e representantes
Titulares
Immodulon Therapeutics Limited
Representantes
Alexandra MacKay Stites & Harbison, PLLC
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Vaccines; immune modulatorspharmaceutical preparations for treatment of immune system related diseasesdisordersdysregulation; vitamins and vitamin preparations
Classe 42
Scientific and technological services and research and design relating theretoresearch and development in the pharmaceutical and biotechnology fields; scientific and industrial analysis and research servicesresearch relating to immune system related diseases and disorders; clinical research in the field of medical sciencemedical and scientific research in the nature of conducting clinical trials; research and development services in the fields of drug discoverydrug discovery productspharmaceuticalsmedicinal diagnosticsbiological productsmedical apparatusdevices and instrumentspharmaceutical drug development services; supply of information in the area of laboratory technologyproviding technology information in the medical diagnostic industry; medical laboratory services; provision of scientific information via Internet portalsproviding scientific information in the field of immunotherapy products in the nature of pharmaceutical preparations for the treatment of immune system related diseasedisorderdysregulation; scientific consultancyconsulting services in the field of the research and development of immunotherapy products in the nature of pharmaceutical preparations for the treatment of immune system related diseasedisorderdysregulation; consultancy and research in the fields of science and technologyresearch in the pharmaceutical and biotechnology fields; laboratory analysis and diagnostic serviceslaboratory services in the nature of analysis and diagnosis of immune dysregulation; technical consultation and research in the fields of biotechnology and drug discovery; product research and development; providing databases in the fields of science and technologyproviding an on-line computer database in the field of medical and scientific research of immune dysregulation
Classe 44
Medical and therapeutic servicestreatment of patients with immuno disorders; medicalhygienic and beauty care for human beings; provision of medical information; advisory services relating to medical servicespreparations and apparatusproviding medical informationconsultancy and advisory services; providing information and advice in the field of healthcare; providing databases and information in the field of healthproviding an on-line computer database featuring information regarding health and nutrition
Publicações
Histórico de despachos e eventos da marca no USPTO.
28 publicações encontradas
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
31/12/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/05/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
16/04/2020
FIMP
FINAL DISPOSITION PROCESSED
16/04/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
31/03/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
31/12/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/10/2019
PUBO
PUBLISHED FOR OPPOSITION
15/10/2019
GPNX
NOTIFICATION PROCESSED BY IB
12/10/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
25/09/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
25/09/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/09/2019
ALIE
ASSIGNED TO LIE
12/09/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/09/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/09/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/09/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/09/2019
RFNT
REFUSAL PROCESSED BY IB
06/04/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
21/03/2019
RFRR
REFUSAL PROCESSED BY MPU
21/03/2019
MAFR
APPLICATION FILING RECEIPT MAILED
15/03/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/03/2019
CNRT
NON-FINAL ACTION WRITTEN
12/03/2019
DOCK
ASSIGNED TO EXAMINER
11/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/03/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
08/03/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
28/02/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace IMMODULON ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.